Trial
NCT00891033
Panobinostat/Velcade in Multiple Myeloma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Arkansas
Collaborators
Novartis
Condition
Multiple Myeloma
Intervention
Bortezomib (Velcade)
Why stopped
This study was terminated because the drug company stopped making the study drug
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-02-23